this article discusses the concept , drawn from clinical and experimental studies , that demonstrate that the additional increased risk of lv hypertrophy may be ascribed to loss of reserve cardiac function , accelerated atherosclerosis , development of abnormal cardiac rhythm secondary to ischemia , fibrosis or drug-induced hypokalemia , inherent predisposition to ventricular dysrhythmias and sudden death , risks directly or coincidentally related to associated diseases or perhaps even the paradoxical risk of beneficial antihypertensive therapy .
C0003811
abnormal cardiac rhythm
C0085612
ventricular